Tyche Partners

Tyche Partners is a private venture capital firm focused primarily on early and early-growth-stage HardTech companies rather than a therapeutic biotech or healthcare operating company. The firm invests in disruptive technologies across areas such as cloud and enterprise infrastructure, 3D printing and advanced manufacturing, robotics and automation, artificial intelligence, semiconductors, and related deep-tech sectors. It appears to operate as an active investment manager led by founder and managing partner Weijie Yun, with additional partners and advisors drawn from technology and venture backgrounds. Based on available public information, Tyche Partners is not itself a drug developer, healthcare provider, CRO, CMO, or biopharma company, and it does not disclose an internal therapeutic pipeline.